STOCK TITAN

Organigram Holdings Inc. Common Shares - OGI STOCK NEWS

Welcome to our dedicated page for Organigram Holdings Common Shares news (Ticker: OGI), a resource for investors and traders seeking the latest updates and insights on Organigram Holdings Common Shares stock.

OrganiGram Holdings Inc. (symbol: OGI) is a leading licensed producer of cannabis, based in Atlantic Canada. As part of Canada’s Marihuana for Medical Purposes Regulations (MMPR), OrganiGram specializes in the cultivation of high-quality, organically grown medical marijuana. The company is committed to providing the best possible medicine and service to its clients.

OrganiGram’s primary operations revolve around the production of indoor-grown cannabis for both medical patients and adult recreational users in Canada. The company has built a diverse portfolio of adult-use recreational cannabis brands including Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, and Trailblazer. Recently, Organigram has expanded its brand lineup with the addition of Tremblant Cannabis and the artisanal craft brand, Laurentian.

OrganiGram has garnered recognition for its innovative and high-quality cannabis products. The company places a strong emphasis on research and development to continually improve its cultivation techniques and product offerings. OrganiGram has also established significant partnerships which support its growth and expansion plans.

Financially, OrganiGram has shown resilience and adaptability in a competitive market. The company regularly updates investors and stakeholders with the latest developments and financial results, ensuring transparency and fostering trust.

OrganiGram Holdings Inc. is dedicated to advancing the cannabis industry through sustainable practices and a commitment to quality. For more information or inquiries, visit www.organigram.ca or contact their client services team at 1-855-961-9420.

Rhea-AI Summary
Organigram Holdings Inc. (OGI) announces Derrick West's transition away from his role as CFO to focus on health and recovery. Paolo De Luca appointed as interim CFO while the company searches for a permanent replacement. CEO Goldenberg expresses gratitude for West's contributions.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.03%
Tags
none
-
Rhea-AI Summary
Organigram Holdings Inc. announces a C$124.6 million investment from BT DE Investments Inc., a subsidiary of BAT. The investment will be used to create a strategic investment pool called Jupiter, expand Organigram's geographic footprint, and enhance the product development collaboration between BAT and Organigram. BAT's voting Common Share ownership position will increase to 30% and overall equity interest to 45%. The investment strengthens Organigram's financial position and enables long-term growth.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.19%
Tags
none
-
News
Rhea-AI Summary
Organigram Holdings achieves #2 market share position in the last two months driven by success in pre-roll business and category leadership in hash and gummies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none
Rhea-AI Summary
Organigram Holdings obtains receipt for final short form base shelf prospectus
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.5%
Tags
none
-
Rhea-AI Summary
Organigram Holdings Inc. has filed a preliminary short form base shelf prospectus, allowing them to distribute up to C$500,000,000 of securities. This provides flexibility for financing options to pursue the company's objectives.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.38%
Tags
none
-
Rhea-AI Summary
Caroline Ferland resigns from Organigram's Board of Directors, leaving for a new role at BAT. She made considerable contributions to the company. BAT expects to appoint a replacement nominee.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
management
Rhea-AI Summary
Organigram launches its first range of THCV products through its SHRED and Trailblazer brands, thanks to its strategic investment in Phylos Bioscience. Organigram is the only Canadian licensed producer to cultivate and extract THCV in-house. THCV is gaining popularity for its appetite suppressing effects and non-psychoactive properties. Organigram has exclusive Canadian rights to high-THCV cultivars from Phylos. The company's THCV products include SHRED'ems Guava Lime Go-Time and Trailblazer Zen Garden Grapefruit, offering unique cannabinoid experiences with high THC:THCV ratios.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
none
-
Rhea-AI Summary
Organigram relaunches Trailblazer brand with new product lineup targeting a $1.2B segment of the cannabis market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.1%
Tags
none
-
Rhea-AI Summary
Organigram has entered into a supply agreement with 4C LABS to provide dried Medical Cannabis flower to the UK market. The agreement is expected to reach approximately 600 kilograms of high-margin Medical Cannabis flower in the first year, with increasing targets in the following years. Organigram will also grant limited strain exclusivity to cultivars distributed by 4C LABS. This expands Organigram's international supply agreements, reflecting their strategy to expand beyond Canada into international markets.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-2.94%
Tags
none
Rhea-AI Summary
Organigram Holdings Inc. has been granted a judicial review by the Federal Court of Canada regarding Health Canada's classification of their Edison Jolts lozenges as edible cannabis. The Court found a breach of procedural fairness and the matter is being sent back to Health Canada for reconsideration. Organigram is pleased with the outcome and looks forward to further review of their ingestible extract.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.73%
Tags
none

FAQ

What is the current stock price of Organigram Holdings Common Shares (OGI)?

The current stock price of Organigram Holdings Common Shares (OGI) is $1.52 as of November 22, 2024.

What is the market cap of Organigram Holdings Common Shares (OGI)?

The market cap of Organigram Holdings Common Shares (OGI) is approximately 166.1M.

What is OrganiGram Holdings Inc.?

OrganiGram Holdings Inc. is a Canadian company engaged in the production of indoor-grown cannabis for medical patients and adult recreational users.

What types of cannabis products does OrganiGram offer?

OrganiGram offers a range of cannabis products under brands such as Edison, Big Bag o' Buds, SHRED, Monjour, Holy Mountain, Trailblazer, Tremblant Cannabis, and Laurentian.

Where is OrganiGram Holdings Inc. based?

OrganiGram Holdings Inc. is based in Atlantic Canada.

How can I contact OrganiGram's client services team?

You can contact OrganiGram's client services team by calling 1-855-961-9420.

Is OrganiGram involved in research and development?

Yes, OrganiGram places a strong emphasis on research and development to enhance its cultivation techniques and product offerings.

What regulations does OrganiGram operate under?

OrganiGram operates under Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Is OrganiGram Holdings Inc. publicly traded?

Yes, OrganiGram Holdings Inc. is publicly traded under the symbol OGI.

Where can I find more information about OrganiGram?

You can find more information about OrganiGram by visiting their website at www.organigram.ca.

What makes OrganiGram's cannabis products unique?

OrganiGram's cannabis products are unique due to their high quality, organically grown nature, and diverse brand portfolio.

Has OrganiGram recently expanded its product lineup?

Yes, OrganiGram has recently added Tremblant Cannabis and the artisanal craft brand, Laurentian to its product lineup.

Organigram Holdings Inc. Common Shares

Nasdaq:OGI

OGI Rankings

OGI Stock Data

166.12M
75.87M
31.32%
9.73%
2.11%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Toronto